Neeman & Industry News
DCGI to implement e-Gov in its working The Drugs Controller General of India (DCGI) to have a single window facility for drug approval soon...
New Indian Regulatory Guidance by Central Drugs Standard Control Organization Guidance for Industry on Submission of Clinical Trial Application for Evaluating Safety and Efficacy - Central Drugs Standard Control Organization...
Indian Clinical Data Management market is expected to ramp up to $150 million MNCs are more than willing to outsource their needs to India because of it\'s technological innovation, creditable quality, operational flexibility, cost effectiveness, time-to-market and competitive advantage according to Koteshwar Govind, Deputy Manager,...
India: Attractive Market for Biopharmaceutical Companies Looking to Accelerate Their Clinical Trials The Clinical Research Market in India is growing at a very rapid rate according to anyone’s statistics…It is exploding according to all the hype. ...

Neeman News

 
Max Neeman International Expands its Pharmacy Services facility in Delhi
Max Neeman International, a leading India based Contract Research Organization and subsidiary of the Max India group, expands its Pharmacy services facility in Delhi to over 4000 square feet.

Research Triangle Park, NC (PR Newswire) December 1, 2009 – Max Neeman Pharmacy services were initiated in 2001 and have expanded over the years serving the top most pharmaceutical companies globally. The facility which was originally set up in an area of 2000 sq. ft. has now doubled in size. Pharmacy services, as part of the suite of services by Max Neeman, are recognized by the global pharma industry as a valuable offering.

The pharmacy inventory management process is considerably robust with highly secure systems. Product distribution is efficient because of strong relationships with the best drug courier companies.

The facility has been successfully audited by more than forty international and national sponsors to date. The expansion of the facility is driven by Max Neeman International’s proliferating client base and has enhanced our capacity in rendering services to several customers.

About Max Neeman International

Max Neeman International is one of the leading and largest CROs in India. Our specialty is that we offer services for the successful conduct of Phase II-IV clinical and device trials for small and mid-sized international and national Pharmaceutical, Biotechnology, Medical Device and Nutraceutical companies in compliance with ICH GCP standards. Operational since 2001, Max Neeman is an ISO 9001:2000 certified CRO for Monitoring, Site Management and Data Management Services. The company is presently active in 22 cities with 5 regional offices. Please contact Donald Swankie, Vice President of Business Development for more information (donald.swankie@neeman-medical.com/ +1.919.424.3345). 
http://www.neeman-medical.com